BioAge Labs, Inc. financial data

Symbol
BIOA on Nasdaq
Location
1445 A South 50 Th Street, Richmond, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.8M shares
Common Stock, Shares, Outstanding 34.2M shares
Weighted Average Number of Shares Outstanding, Basic 3.49M shares +109%
Weighted Average Number of Shares Outstanding, Diluted 3.49M shares +109%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 20M USD +206%
General and Administrative Expense 4.73M USD +41%
Operating Income (Loss) -24.8M USD -150%
Nonoperating Income (Expense) 1.34M USD
Net Income (Loss) Attributable to Parent -23.4M USD -60%
Earnings Per Share, Basic -6.7 USD/shares +23.3%
Earnings Per Share, Diluted -6.7 USD/shares +23.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 334M USD
Assets, Current 336M USD
Property, Plant and Equipment, Net 543K USD
Operating Lease, Right-of-Use Asset 271K USD
Assets 337M USD
Accounts Payable, Current 2.1M USD
Employee-related Liabilities, Current 2.97M USD
Liabilities, Current 19.1M USD
Liabilities 23.6M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 109K USD
Retained Earnings (Accumulated Deficit) -232M USD
Stockholders' Equity Attributable to Parent 314M USD
Liabilities and Equity 337M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500M shares
Common Stock, Shares, Issued 34.2M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23.3M USD -60%
Property, Plant and Equipment, Gross 1.08M USD
Operating Lease, Liability, Current 273K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 200K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 545M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 1.85M USD +144%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares